The results of Kang et al. correlated with our findings, showing no difference in tumour growth between their group receiving the [177Lu]Lu-CD38 probe and [177Lu]Lu-Ig irrelevant in a low CD38+ expressing model due to the similar tumour uptake between the two groups. This evidence concerns the gene CD38 and neoplasm.